levamisole has been researched along with Cancer of Kidney in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aksoy, H; Baltaci, S; Bedük, Y; Seçkiner, I; Türkölmez, K | 1 |
Hausner, L; Hrycek, A; Kalina, Z; Wittek, A | 1 |
A'Hern, R; Ahmed, FY; Atkinson, H; Gore, ME; Leonard, GA; Lorentzos, A; Moore, J; Nicolson, MC; Riches, PG; Taylor, AE | 1 |
Creagan, ET; Hestorff, RD; Krook, JE; Kugler, JW; Mailliard, JA; Marschke, RF; Michalak, JC; Nair, S; Suman, VJ; Tschetter, LK | 1 |
Buzogány, I; Döbrönte, R; Fazekas, A; Kaiser, L; Magyarlaki, T; Nagy, J; Simon, B; Sükösd, F | 1 |
Murphy, GP; Wajsman, Z; Williams, PD | 1 |
Böttger, I; Hofmann, R; Lehmer, A; Reidel, G; Schütz, W | 1 |
2 trial(s) available for levamisole and Cancer of Kidney
Article | Year |
---|---|
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma.
Topics: Adjuvants, Immunologic; Adult; Carcinoma, Renal Cell; Humans; Interleukin-2; Kidney Neoplasms; Leukocyte Count; Levamisole; Lymphocytes; Melanoma | 1996 |
Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II study.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Therapy, Combination; Female; Humans; Interleukin-2; Kidney Neoplasms; Levamisole; Male; Middle Aged; Recombinant Proteins; Survival Analysis | 1998 |
5 other study(ies) available for levamisole and Cancer of Kidney
Article | Year |
---|---|
Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.
Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Renal Cell; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Levamisole; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Treatment Outcome | 2001 |
[Effect of levamisole on peripheral blood neutrophils in patients with neoplasms].
Topics: Aged; Female; Humans; Kidney Neoplasms; Leukocyte Count; Levamisole; Lung Neoplasms; Male; Middle Aged; Neutropenia; Neutrophils; Stomach Neoplasms | 1984 |
Prognostic histological and immune markers of renal cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Progression; Follow-Up Studies; Humans; Immunoenzyme Techniques; Immunologic Factors; Immunotherapy; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Levamisole; Lymphocytes, Tumor-Infiltrating; Neoplasm Proteins; Neoplasm Staging; Nephrectomy; Prognosis; Recombinant Proteins; Treatment Outcome; Vinblastine | 2001 |
The value of levamisole in a Wilms' tumor animal model.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Kidney Neoplasms; Levamisole; Male; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Rats, Inbred WF; Wilms Tumor | 1978 |
Natural killer cells in patients with renal cell cancer.
Topics: Bacterial Outer Membrane Proteins; Carcinoma, Renal Cell; Cell Line; Humans; Interferons; Kidney Neoplasms; Killer Cells, Natural; Levamisole | 1985 |